Lymphoplasmacytic non-Hodgkin lymphoma/Waldenström's macroglobulinemia with CD5+, CD23+, and CD10-
- PMID: 24466560
- PMCID: PMC3894394
- DOI: 10.5045/br.2013.48.4.300
Lymphoplasmacytic non-Hodgkin lymphoma/Waldenström's macroglobulinemia with CD5+, CD23+, and CD10-
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Figures



Similar articles
-
CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia.Clin Lymphoma. 2005 Mar;5(4):246-9. doi: 10.3816/clm.2005.n.008. Clin Lymphoma. 2005. PMID: 15794857
-
L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.PLoS One. 2013 Nov 5;8(11):e80088. doi: 10.1371/journal.pone.0080088. eCollection 2013. PLoS One. 2013. PMID: 24224040 Free PMC article.
-
Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.J Med Case Rep. 2020 Jul 13;14(1):98. doi: 10.1186/s13256-020-02404-x. J Med Case Rep. 2020. PMID: 32654665 Free PMC article.
-
Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.Best Pract Res Clin Haematol. 2016 Jun;29(2):179-186. doi: 10.1016/j.beha.2016.08.014. Epub 2016 Aug 23. Best Pract Res Clin Haematol. 2016. PMID: 27825464 Free PMC article. Review.
-
B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.Semin Hematol. 1999 Apr;36(2):104-14. Semin Hematol. 1999. PMID: 10319379 Review.
Cited by
-
A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation.Int J Hematol. 2020 Feb;111(2):317-323. doi: 10.1007/s12185-019-02734-7. Epub 2019 Sep 21. Int J Hematol. 2020. PMID: 31542852
References
-
- Waldenstrom J. Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia: a new syndrome? Acta Med Scand. 1944;117:216–247.
-
- Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30:110–115. - PubMed
-
- Tournilhac O, Santos DD, Xu L, et al. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann Oncol. 2006;17:1275–1282. - PubMed
-
- Mansoor A, Medeiros LJ, Weber DM, et al. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001;116:543–549. - PubMed
-
- Treon SP, Hunter ZR. A new era for Waldenstrom macroglobulinemia: MYD88 L265P. Blood. 2013;121:4434–4436. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources